PGNY is expected to report earnings to fall 42.65% to 31 cents per share on October 29
Q3'26
Est.
$0.32
Q2'26
Beat
by $0.21
Q1'26
Beat
by $0.24
Q4'25
Beat
by $0.34
Q3'25
Beat
by $0.32
The last earnings report on August 06 showed earnings per share of 55 cents, beating the estimate of 34 cents. With 400.17K shares outstanding, the current market capitalization sits at 1.97B.
A.I. Advisor
published General Information
General Information
a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools
A.I.dvisor indicates that over the last year, PGNY has been loosely correlated with CLSK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PGNY jumps, then CLSK could also see price increases.
PGNY in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 06, 2026
PGNY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where PGNY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PGNY's RSI Oscillator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where PGNY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 31, 2026. You may want to consider a long position or call options on PGNY as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PGNY just turned positive on August 31, 2026. Looking at past instances where PGNY's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PGNY advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
PGNY moved below its 50-day moving average on August 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PGNY crossed bearishly below the 50-day moving average on August 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PGNY entered a downward trend on August 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PGNY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.348) is normal, around the industry mean (3.649). P/E Ratio (27.913) is within average values for comparable stocks, (148.757). PGNY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.210). PGNY's Dividend Yield (0.000) is considerably lower than the industry average of (0.020). PGNY's P/S Ratio (1.702) is very high in comparison to the industry average of (0.566).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PGNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
